Related Experiment Videos
Treatment of Hodgkin's disease at a local hospital
Insights
Local hospitals can effectively treat Hodgkin's disease, achieving survival rates comparable to major cancer centers. This study demonstrates that specialized cancer care is feasible outside of tertiary facilities.
Area of Science:
- Oncology
- Clinical Medicine
- Public Health
Background:
- Hodgkin's disease treatment efficacy at local hospitals remains uncertain.
- Tertiary cancer centers are traditionally considered the standard for specialized cancer care.
- Assessing the quality of care for Hodgkin's disease in non-specialized settings is crucial.
Purpose of the Study:
- To evaluate the adequacy of Hodgkin's disease treatment at a local hospital.
- To compare treatment outcomes at a local hospital with those reported by tertiary cancer centers.
- To determine the feasibility of providing comparable cancer care in community settings.
Main Methods:
- Retrospective analysis of 40 patients with Hodgkin's disease treated between 1978 and 1991.
- Assessment of disease-free survival rates at 3 and 10 years post-treatment.
- Comparison of observed survival rates with published data from tertiary cancer centers.
Main Results:
- Disease-free survival rates of 90% (36/40) at 3 years and 83% (19/23) at 10 years were achieved.
- These outcomes are comparable to survival rates reported by leading cancer institutions.
- The Carmel Medical Center demonstrated successful management of Hodgkin's disease.
Conclusions:
- Hodgkin's disease can be adequately treated at local hospitals, challenging the necessity of exclusive tertiary care.
- Local hospital treatment offers comparable outcomes to specialized cancer centers.
- Further research is recommended to validate these findings across other community hospitals.
Abstract:
It is unclear whether patients with Hodgkin's disease can be adequately treated at local hospitals. From 1978 through 1991, 40 patients with Hodgkin's disease were treated at the Carmel Medical Center. Disease-free survival was 36/40 (90%) and 19/23 (83%) after 3 and 10 years follow-up, respectively. These results are comparable to those reported by tertiary cancer centers. We conclude that adequate treatment for patient's with Hodgkin's disease can be given at local hospitals. Further studies are warranted to determine if our results can be extrapolated to other local hospitals.